GGrantIndex
← Leaderboards

Emanual M. Maverakis

University Of California, San Francisco

$6,125,352
Attributed
$7,320,474
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200825
$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,320,474 · 6

By mechanism

DP2$2,819,043 · 1
R01$2,390,244 · 1
K24$938,550 · 1
S10$599,752 · 1
K08$349,025 · 1
R03$223,860 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsInterestMediatingAutoimmunityPlayBaseT-LymphocyteTissuesAutoimmune DiseasesIn VitroIn VivoSamplingProteinsProtocols DocumentationPhysiciansImmune SystemMentorsScientistInflammatoryFutureCytokineImmune ResponsePhase 1 StudySeverity Of Illness

Grant awards (17)

HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation$781,939
R01 · FY2025 · AI
Mentoring Translational Scientists in Clinical Trial Immune Monitoring$187,710
K24 · FY2025 · AR · contact PI
HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation$804,996
R01 · FY2024 · AI
Mentoring Translational Scientists in Clinical Trial Immune Monitoring$187,710
K24 · FY2024 · AR · contact PI
HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation$803,309
R01 · FY2023 · AI
Mentoring Translational Scientists in Clinical Trial Immune Monitoring$187,710
K24 · FY2023 · AR · contact PI
Stratedigm S100EON high-parameter flow cytometer to support multi-institutional research programs$599,752
S10 · FY2022 · OD · contact PI
Mentoring Translational Scientists in Clinical Trial Immune Monitoring$187,710
K24 · FY2022 · AR · contact PI
Mentoring Translational Scientists in Clinical Trial Immune Monitoring$187,710
K24 · FY2021 · AR · contact PI
Investigation and Development of New Therapeutic Avenues for Scleroderma$510,250
DP2 · FY2016 · OD · contact PI
Characterization of Pathogenic T cells in Alopecia Areata$73,800
R03 · FY2012 · AR · contact PI
Investigation and Development of New Therapeutic Avenues for Scleroderma$2,308,793
DP2 · FY2011 · OD · contact PI
Characterization of Pathogenic T cells in Alopecia Areata$73,560
R03 · FY2011 · AR · contact PI
gC399tr an inhibitor of autoimmunity$118,995
K08 · FY2010 · AI · contact PI
Characterization of Pathogenic T cells in Alopecia Areata$76,500
R03 · FY2010 · AR · contact PI
gC399tr an inhibitor of autoimmunity$116,316
K08 · FY2009 · AI · contact PI
gC399tr an inhibitor of autoimmunity$113,714
K08 · FY2008 · AI · contact PI